StemPro® MSC SFM CTS"
Published November 13, 2019 · Recall initiated: June 11, 2019
Summary
FDA records medical device Class II recall Z-0274-2020, published November 13, 2019 and initiated June 11, 2019. Recalling firm: Life Technologies Corporation; Status: Terminated; Reported quantity: 4724 Kits; Lot: SKU#: A1033301; Lot # 556094 (Exp 2/28/2010), 577934 (Exp 4/30/2010) , 883643 (Exp 12/30/2011), 987595 (Exp 6/30/2013), 1607880 (Exp 6/30/2016), 1936294 (Exp 11/30/2019), 1960237 (Exp 4/30/2020), 2015107 (Exp 10/30/2020), 2049317 (Exp 11/30/2020), 2074105 ( Exp2/28/2021). Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Component was not tested by the supplier for adventitious agents
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Life Technologies Corporation
- Distributor
- StemPro® MSC SFM CTSTM distributed to the following states in the USA: AL, CA, CO, CT, DC, FL, GA, IA, IL, KS, MA, MD, MN, NC, NE, NJ, NY,OH, OR, PA, RI, TX, UT, VA, WA, WI. StemPro® MSC SFM CTSTM distributed Internationally to the following countries: Australia, Belgium, Brazil, Canada, Chile, China, Croatia, Czech Republic, Denmark, France, Germany, Hong Kong, India, Indonesia, Iraq, Israel, Italy, Japan, Jordan, Kazakhstan, Malaysia, Netherlands, Pakistan, Poland, Republic of Korea, Saudi Arabia, Singapore, South Africa, Spain, Sweden, Taiwan, Thailand, Ukraine, United Kingdom, Vietnam. CTSTM Essential 8 Medium distributed to the following states in the USA: CA, DC, FL, IA, IL, MA, MD, MN, NC, NY, WA, WI. CTSTM Essential 8 Medium distributed Internationally to the following countries: Australia, Canada, China, France, Germany, India, Japan, Netherlands, Portugal, Republic of Korea, Saudi Arabia, Singapore, Sweden, Switzerland, Taiwan, United Kingdom.
- Lot
- SKU#: A1033301; Lot # 556094 (Exp 2/28/2010), 577934 (Exp 4/30/2010) , 883643 (Exp 12/30/2011), 987595 (Exp 6/30/2013), 1607880 (Exp 6/30/2016), 1936294 (Exp 11/30/2019), 1960237 (Exp 4/30/2020), 2015107 (Exp 10/30/2020), 2049317 (Exp 11/30/2020), 2074105 ( Exp2/28/2021)
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDATorrent Suite Dx Software versions 5.14 and earlier used in connection with Ion PGM DX Systems-IVD intendedApril 10, 2024
- FDAThe TaqPath RT-PCR COVID-19 Kit with Applied Biosystem's COVID-19 Interpretive Software v2.0 or v2.2 (usedSeptember 23, 2020
- FDAVITROS chemistry Products K+ Slides, Catalog No. 8157596. MicroSlides which contain reagents in a dry,November 13, 2019
- FDAPrismaflex Control Unit, software versions below 7.21November 13, 2019
- FDALow Level Output Cable Interface to Philips Monitor For Use With Cardiosave and CS300 Intra-Aortic BalloonNovember 13, 2019
- FDAHSV 2 Primers, Catalog #18081020. Analyte Specific Reagent. The HSV-2 primer pair is specific for HSV-2September 4, 2013
Questions about this recall
Was StemPro® MSC SFM CTS" recalled?
Yes. FDA published recall Z-0274-2020 on November 13, 2019. Reported hazard: Component was not tested by the supplier for adventitious agents
What should I do if I have this product?
Voluntary: Firm initiated · Letter